The phase III ICE study: Adjuvant Ibandronate with or without capecitabine in elderly patients with moderate or high risk early breast cancer

This article has no abstract
Epistemonikos ID: cc6342cb7398e2d651038cb30bc87161d8621128
First added on: Feb 07, 2025